caffeine has been researched along with levonorgestrel in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Balogh, A; Hempel, E; Hoffmann, A; Irmisch, E; Klinger, G; Letrari, S; Splinter, FK; Wolf, P | 1 |
| Balogh, A; Börner, A; Henschel, L; Klinger, G; Kuhnz, W; Vollanth, R | 1 |
| Aboulfadl, K; Barbeau, B; Broséus, R; Daneshvar, A; Prévost, M; Sauvé, S; Vincent, S | 1 |
1 review(s) available for caffeine and levonorgestrel
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for caffeine and levonorgestrel
| Article | Year |
|---|---|
Influence of ethinylestradiol-containing combination oral contraceptives with gestodene or levonorgestrel on caffeine elimination.
Topics: Administration, Oral; Adult; Caffeine; Contraceptives, Oral; Estradiol; Female; Humans; Kinetics; Levonorgestrel; Norpregnenes; Time Factors; Volunteers | 1995 |
6 other study(ies) available for caffeine and levonorgestrel
| Article | Year |
|---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Effect of levonorgestrel and ethinyl estradiol and their combination on biotransformation reactions].
Topics: Adult; Biotransformation; Caffeine; Contraceptives, Oral, Combined; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dipyrone; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Metabolic Clearance Rate | 1991 |
Ozone oxidation of pharmaceuticals, endocrine disruptors and pesticides during drinking water treatment.
Topics: Caffeine; Endocrine Disruptors; Estradiol; Estriol; Estrogens; Estrone; Hydrogen-Ion Concentration; Levonorgestrel; Medroxyprogesterone; Molecular Structure; Norethindrone; Oxidation-Reduction; Ozone; Pesticides; Pharmaceutical Preparations; Progesterone; Water Pollutants, Chemical; Water Purification; Water Supply | 2009 |